Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Kang KD, Bernstock JD, Totsch SK, Gary SE, et al. Clin Cancer Res 2022;28:5419-5430.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kang KD, Bernstock JD, Totsch SK, Gary SE, et al. Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clin Cancer Res 2022;28:5419-5430.
PMID: 36239623